DC
ARNA

Deere & Company’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Deere & Company’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,653
Closed -$389K – 1084
2013
Q4 		$389K Buy
6,653
+3,819
+135% +$200K 0.02% 720
2013
Q3 		$149K Buy
+2,834
New +$190K 0.01% 952

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Deere & Company's ARNA Position: Q1 2014 in Review

Deere & Company sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2014, closing a stake of 6,653 shares — an estimated $389K sold.

Deere & Company first reported a position in ARNA in Q3 2013 and held it in 2 quarters. The position peaked at $389K in Q4 2013. 131 funds tracked by Wall St. Rank hold ARNA as of Q1 2014.

  • Deere & Company reported no remaining Arena Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Deere & Company sold 6,653 Arena Pharmaceuticals Inc shares in Q1 2014, an estimated $389K.
  • Deere & Company first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 2 quarters.
  • Deere & Company's Arena Pharmaceuticals Inc position peaked at $389K in Q4 2013.
  • 131 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2014.

Based on Deere & Company's 13F filing for Q1 2014, filed 8 May 2014.